Category :

Busting fear barrier about hormone replacement therapy in new era of menopause management

MANILA,Philippines,May 24,2024-- Millions of women around the world continue to suffer unnecessarily from the physical and psychological effects of the menopause because of "mistaken fears"

EnergyMay 30, 2024

URBAN SPORTS AND STREET ARTS MEET IN SINGAPORE AS PART OF A GLOBAL WARM-UP TO THE PARIS 2024 OLYMPIC GAMES

The unique event,which is among the first global events created to build excitement for the upcoming Olympic Games,sees French andSingaporeans athletes and artists coming together to revitalise the ic

Chip TechMay 30, 2024

Friso Launches #MovetoGoodPoop Movement to Champion Good Gut Health in Children with Music and Storytelling

Homegrown singer-songwriter-producer Derrick Hoh announced as Friso Brand Ambassador for 2024/25 SINGAPORE,May 24,2024--Friso,a leading nutrition formula milk brand with over 150 years of Dutch dairy

EnergyMay 30, 2024

Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting

The ELECTRA and ELEVATE studies were designed to overcome different resistance mechanisms and improve patient outcomes with oral-oral combination options.

SoftwareMay 30, 2024

Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024

Phase II results reveal median PFS of 12.6 months in patients with CLDN18.2 high or medium expression,including in patients with PD-L1 CPS<5.

TechMay 30, 2024

Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024

Phase II results reveal median PFS of 12.6 months in patients with CLDN18.2 high or medium expression,including in patients with PD-L1 CPS<5.

ScienceMay 30, 2024

Dizal Reveals New Findings from Biomarker Analysis, Highlighting Sunvozertinib as an Effective Treatment for Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Antitumor efficacy of sunvozertinib was observed in patients regardless of baseline EGFR exon20ins status in plasma ctDNA.

SpaceMay 30, 2024

New Oriental Extends Share Repurchase Program

BEIJING,May 24,2024-- New Oriental Education & Technology Group Inc. ("New Oriental" or the "Company") (NYSE:EDU and SEHK: 9901),a provider of private educational services in C

EnergyMay 30, 2024

Tyligand Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a Selective and Orally Bioavailable KRAS G12D Inhibitor

SHANGHAI,May 24,2024--Tyligand Bioscience,a clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies,announced that the first patient had been dosed

Big DataMay 30, 2024

Newrizon Partnered With Al Yemni Group, Bringing Its Futuristic EV Truck In GCC Region

RIYADH,Saudi Arabia,May 24,2024-- Recently in Riyadh,Newrizon,a startup dedicated in electrifying and revolutionizing urban delivery vehicles,signed dealership agreement and intent purchase order with

BiologyMay 30, 2024
Your premier source for cutting-edge news in the realms of technology, artificial intelligence, energy, and more. Explore the future of tech with Arinstar! Stay informed, stay inspired!

Quick Search

Explore our curated content, stay informed about groundbreaking innovations, and journey into the future of science and tech.

© ArinstarTechnology

Privacy Policy